Drug profile · INN
dyclonine hydrochloride
DYCLONE
dyclonine hydrochloride (DYCLONE) is a sodium channel alpha subunit blocker. Route of administration: topical. Current US regulatory status: approved.
Drug details — dyclonine hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
dyclonine hydrochloride (DYCLONE) is a sodium channel alpha subunit blocker. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dyclonine hydrochloride?
dyclonine hydrochloride (DYCLONE) is a sodium channel alpha subunit blocker. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for dyclonine hydrochloride?
DYCLONE is a marketed brand name for dyclonine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dyclonine hydrochloride?
dyclonine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.